{"id":"https://openalex.org/W116198138","doi":null,"title":"Dose-finding study of anti-CD25 antibody for targeting regulatory T cells in locoregional immunotherapy of malignant effusion.","display_name":"Dose-finding study of anti-CD25 antibody for targeting regulatory T cells in locoregional immunotherapy of malignant effusion.","publication_year":2008,"publication_date":"2008-03-01","ids":{"openalex":"https://openalex.org/W116198138","mag":"116198138","pmid":"https://pubmed.ncbi.nlm.nih.gov/18578365"},"language":"en","primary_location":{"id":"pmid:18578365","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18578365","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hiroshima journal of medical sciences","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://hiroshima.repo.nii.ac.jp/records/2013600","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015634516","display_name":"Makoto Okawaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I113306721","display_name":"Hiroshima University","ror":"https://ror.org/03t78wx29","country_code":"JP","type":"education","lineage":["https://openalex.org/I113306721"]},{"id":"https://openalex.org/I4405287266","display_name":"Research Institute for Radiation Biology and Medicine, Hiroshima University","ror":"https://ror.org/04mfv5z87","country_code":"JP","type":"facility","lineage":["https://openalex.org/I113306721","https://openalex.org/I4405287266"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Makoto Okawaki","raw_affiliation_strings":["Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Kasumi 1-2-3, Minami-hu, Hiroshima 734-8551, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Kasumi 1-2-3, Minami-hu, Hiroshima 734-8551, Japan","institution_ids":["https://openalex.org/I113306721","https://openalex.org/I4405287266"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025758494","display_name":"Yoshiyuki Yamaguchi","orcid":"https://orcid.org/0000-0001-5895-9044","observed_orcids":["https://orcid.org/0000-0001-5895-9044"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yoshiyuki Yamaguchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069392282","display_name":"Riki Okita","orcid":"https://orcid.org/0000-0003-1343-1275","observed_orcids":["https://orcid.org/0000-0003-1343-1275"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Riki Okita","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040303815","display_name":"Masahiro Ohara","orcid":"https://orcid.org/0000-0003-4174-5052","observed_orcids":["https://orcid.org/0000-0003-4174-5052"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masahiro Ohara","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5013107055","display_name":"Morihito Okada","orcid":"https://orcid.org/0000-0001-7068-6608","observed_orcids":["https://orcid.org/0000-0001-7068-6608"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Morihito Okada","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4017,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.60533815,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"57","issue":"1","first_page":"37","last_page":"46"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.9574999809265137,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.9574999809265137,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00800000037997961,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.007199999876320362,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/basiliximab","display_name":"basiliximab","score":0.9200000166893005},{"id":"https://openalex.org/keywords/anti-cd25-antibody","display_name":"anti-CD25 antibody","score":0.9539999961853027},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.9940000176429749},{"id":"https://openalex.org/keywords/malignant-effusions","display_name":"malignant effusions","score":0.8180000185966492},{"id":"https://openalex.org/keywords/ok-432","display_name":"OK-432","score":0.996999979019165},{"id":"https://openalex.org/keywords/low-dose-immunotherapy","display_name":"low-dose immunotherapy","score":0.7080000042915344},{"id":"https://openalex.org/keywords/dose-finding","display_name":"dose-finding","score":0.6909999847412109},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.7870000004768372},{"id":"https://openalex.org/keywords/foxp3","display_name":"Foxp3","score":0.7710000276565552},{"id":"https://openalex.org/keywords/cd4-cd25-regulatory-t-cells","display_name":"CD4+CD25+ T cells","score":0.7699999809265137},{"id":"https://openalex.org/keywords/intracavitary-administration","display_name":"intracavitary administration","score":0.8539999723434448},{"id":"https://openalex.org/keywords/treg-depletion","display_name":"Treg depletion","score":0.5239999890327454}],"concepts":[{"id":"https://openalex.org/C2781307858","wikidata":"https://www.wikidata.org/wiki/Q418702","display_name":"Basiliximab","level":4,"score":0.9010562896728516},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8503161072731018},{"id":"https://openalex.org/C79484868","wikidata":"https://www.wikidata.org/wiki/Q5971673","display_name":"IL-2 receptor","level":4,"score":0.7918730974197388},{"id":"https://openalex.org/C2779727006","wikidata":"https://www.wikidata.org/wiki/Q426188","display_name":"FOXP3","level":3,"score":0.6523346304893494},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5893034934997559},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.5011138916015625},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.5001811981201172},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.47123512625694275},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.43467479944229126},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37896645069122314},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3743499219417572},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.35170695185661316},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.30103689432144165},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25630539655685425},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.2536756992340088},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10384547710418701},{"id":"https://openalex.org/C2780303639","wikidata":"https://www.wikidata.org/wiki/Q740909","display_name":"Kidney transplantation","level":3,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077552","descriptor_name":"Basiliximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001201","descriptor_name":"Ascites","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010844","descriptor_name":"Picibanil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016066","descriptor_name":"Pleural Effusion, Malignant","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016066","descriptor_name":"Pleural Effusion, Malignant","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D050378","descriptor_name":"T-Lymphocytes, Regulatory","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D053645","descriptor_name":"Interleukin-2 Receptor alpha Subunit","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true}],"locations_count":4,"locations":[{"id":"pmid:18578365","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18578365","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hiroshima journal of medical sciences","raw_type":"Journal Article"},{"id":"pmh:oai:irdb.nii.ac.jp:01372:0006666764","doi":null,"is_oa":true,"landing_page_url":"https://hiroshima.repo.nii.ac.jp/records/2013600","pdf_url":null,"source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hiroshima Journal of Medical Sciences","raw_type":"departmental bulletin paper"},{"id":"pmh:oai:hiroshima.repo.nii.ac.jp:02013600","doi":null,"is_oa":true,"landing_page_url":"https://hiroshima.repo.nii.ac.jp/records/2013600","pdf_url":null,"source":{"id":"https://openalex.org/S7407055456","display_name":"Hiroshima University Institutional Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"departmental bulletin paper"},{"id":"pmh:oai:ir.lib.hiroshima-u.ac.jp:00034950","doi":null,"is_oa":false,"landing_page_url":"http://ir.lib.hiroshima-u.ac.jp/00034950","pdf_url":null,"source":{"id":"https://openalex.org/S4377196292","display_name":"Hiroshima University Acedemic Information Repository (Hiroshima University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I113306721","host_organization_name":"Hiroshima University","host_organization_lineage":["https://openalex.org/I113306721"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"departmental bulletin paper"}],"best_oa_location":{"id":"pmh:oai:irdb.nii.ac.jp:01372:0006666764","doi":null,"is_oa":true,"landing_page_url":"https://hiroshima.repo.nii.ac.jp/records/2013600","pdf_url":null,"source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hiroshima Journal of Medical Sciences","raw_type":"departmental bulletin paper"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W1567420244","https://openalex.org/W1971325784","https://openalex.org/W1982395758","https://openalex.org/W1988160732","https://openalex.org/W2016190485","https://openalex.org/W2034818671","https://openalex.org/W2035151186","https://openalex.org/W2043176282","https://openalex.org/W2064172926","https://openalex.org/W2065459312","https://openalex.org/W2066224334","https://openalex.org/W2083259799","https://openalex.org/W2116019574","https://openalex.org/W2138163780","https://openalex.org/W2148523692","https://openalex.org/W2151937278","https://openalex.org/W2159459001","https://openalex.org/W2161901033","https://openalex.org/W2163184777","https://openalex.org/W2340326270","https://openalex.org/W2991834586","https://openalex.org/W4251640819"],"related_works":["https://openalex.org/W2137758676","https://openalex.org/W1974059357","https://openalex.org/W4388578166","https://openalex.org/W2058162671","https://openalex.org/W1585277294","https://openalex.org/W2073772548","https://openalex.org/W1998003739","https://openalex.org/W2212281148","https://openalex.org/W3118545484","https://openalex.org/W2397427241"],"abstract_inverted_index":{"Effects":[0],"of":[1,69,89,108,115,137,161,181,211,215],"low-dose":[2,160,195,224],"anti-CD25":[3,20],"antibody":[4,22],"on":[5,36,122,126,139,145,230,234],"targeting":[6],"regulatory":[7],"T":[8,102],"(Treg)":[9],"cells":[10,42,97,103,168,200],"in":[11,14,104,201,204,243],"vitro":[12,202],"and":[13,43,50,55,66,79,152,158,203,206],"vivo":[15],"were":[16,47,71],"investigated.":[17],"Human-mouse":[18],"chimeric":[19],"monoclonal":[21],"basiliximab":[23,53,92,109,138,164,196,225],"was":[24,120,148,183],"administered":[25],"into":[26],"the":[27,52,132,188,209,219,244],"effusion":[28,44,217],"cavity,":[29],"followed":[30,142,226],"by":[31,73,143,187,227],"locoregional":[32],"immunotherapy":[33,214],"using":[34,155,218],"OK-432":[35,144,156,228],"day":[37,123,127,140,146,231,235],"7.":[38],"Peripheral":[39],"blood":[40],"mononuclear":[41],"lymphocytes":[45],"(ELs)":[46],"collected":[48],"before":[49],"after":[51,129],"administration":[54,136,229],"subjected":[56],"to":[57],"further":[58],"investigations.":[59],"Surface":[60],"phenotypes,":[61],"IFN-gamma":[62],"production,":[63],"cytotoxic":[64],"activity":[65],"foxp3":[67],"expression":[68,180],"ELs":[70,116,182],"assessed":[72],"flow":[74],"cytometry,":[75],"ELISA,":[76],"51Cr-releasing":[77],"assay,":[78],"RT-PCR":[80],"analysis,":[81],"respectively.":[82],"We":[83],"observed":[84],"that":[85,194],"a":[86,159],"low":[87],"concentration":[88,107],"0.01":[90],"microg/ml":[91],"effectively":[93],"targeted":[94],"CD4+CD25(bri)":[95,167],"Treg":[96,199,220],"while":[98,174],"preserving":[99,176],"CD4+CD25(dim)":[100,177],"activated":[101],"vitro.":[105],"This":[106],"significantly":[110],"augmented":[111],"interferon":[112],"(IFN)-gamma":[113],"production":[114],"when":[117],"interleukin":[118],"(IL)-2":[119],"added":[121],"0":[124,141,232],"or":[125,233],"1":[128,236],"basiliximab.":[130,190],"In":[131],"clinical":[133,241],"study,":[134],"intracavitary":[135,189],"7":[147],"as":[149,154],"safe,":[150],"well-tolerated,":[151],"effective":[153],"alone,":[157],"0.002-0.005":[162],"mg/kg":[163],"could":[165],"target":[166,198],"for":[169,240],"at":[170],"least":[171],"3":[172],"days":[173],"relatively":[175],"cells.":[178],"Foxp3":[179],"not":[184],"changed":[185],"definitely":[186],"These":[191],"results":[192],"suggest":[193],"can":[197],"vivo,":[205],"subsequently":[207],"augment":[208],"activation":[210],"ELs.":[212],"Locoregional":[213],"malignant":[216],"cell-conditioning":[221],"regimen":[222],"with":[223],"should":[237],"be":[238],"evaluated":[239],"efficacy":[242],"next":[245],"phase":[246],"II":[247],"trial.":[248]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}